ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
ANGIODYNAMICS INC
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$11.39+0.15 (+1.33%)
Close on Oct 19, 2026
- Market cap
- $478.63M
- P/E (TTM)
- –
- Dividend yield
- –
ANGIODYNAMICS INC revenue by segment
By business segment
| Revenue | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Med Device | – | $41.14M | $43.78M | $40.45M | – | $40.66M | $41.29M | $39.52M | – | – | – | – | – | – |
| Med Tech | – | $37.28M | $35.65M | $35.26M | – | $31.34M | $31.55M | $27.97M | – | – | – | – | – | – |
By product or service
| Revenue | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Med Device | – | $41.14M | $43.78M | $40.45M | – | $40.66M | $41.29M | $39.52M | $41.65M | $49.34M | $53.71M | $52.82M | – | – |
| Med Tech | – | $37.28M | $35.65M | $35.26M | – | $31.34M | $31.55M | $27.97M | $29.34M | $25.84M | $25.36M | $25.86M | – | – |
By region
| Revenue | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $73.60M | $67.28M | $67.59M | $66.46M | $67.48M | $61.34M | $62.68M | $59.48M | $60.74M | $62.34M | $64.00M | $64.40M | 85.0% | +9.1% |
| International | $13.01M | $11.15M | $11.84M | $9.26M | $12.67M | $10.66M | $10.17M | $8.01M | $10.24M | $12.84M | $15.07M | $14.28M | 15.0% | +2.7% |
From the segment and revenue-disaggregation notes of Angiodynamics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.